| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of Effect of Telbivudine on Cardiac Repolarization: Results of a Thorough QT/QTc Study in Healthy Participants
|
Poordad, Fred
|
|
2009
|
|
12 |
p. 1436-1446
|
artikel
|
| 2 |
Absolute Bioavailability and Dose Proportionality of Oral Ganciclovir after Ascending Multiple Doses in Human Immunodeficiency Virus (HIV)-Positive Patients
|
Jung, Donald
|
|
1998
|
|
12 |
p. 1122-1128
|
artikel
|
| 3 |
Absolute Bioavailability, Pharmacokinetics, and Urinary Excretion of the Novel Antimigraine Agent Almotriptan in Healthy Male Volunteers
|
Jansat, Josep M.
|
|
2002
|
|
12 |
p. 1303-1310
|
artikel
|
| 4 |
Absorption, Metabolism, and Excretion of Intravenously and Orally Administered[14C]Telmisartan in Healthy Volunteers
|
Stangier, Joachim
|
|
2000
|
|
12 |
p. 1312-1322
|
artikel
|
| 5 |
A Legal Curriculum for the Clinical Pharmacologist: I. Order of Precedence of Authority
|
Calderwood, James A.
|
|
1992
|
|
12 |
p. 1073-1082
|
artikel
|
| 6 |
Alfentanil-Induced Miosis Clearance as a Liver CYP3A4 and 3A5 Activity Measure in Healthy Volunteers: Improvement of Experimental Conditions
|
Baririan, Narine
|
|
2005
|
|
12 |
p. 1434-1441
|
artikel
|
| 7 |
Altered Phenytoin Pharmacokinetics in Children with Severe, Acute Traumatic Brain Injury
|
Stowe, Cindy D.
|
|
2000
|
|
12 |
p. 1452-1461
|
artikel
|
| 8 |
American College of Clinical Pharmacology
|
|
|
2004
|
|
12 |
p. 1443-1444
|
artikel
|
| 9 |
American College of Clinical Pharmacology
|
|
|
2005
|
|
12 |
p. 1461-1462
|
artikel
|
| 10 |
American College of Clinical Pharmacology
|
|
|
2006
|
|
12 |
p. 1516-1517
|
artikel
|
| 11 |
Analgesic Effect of Sustained-Release Flurbiprofen Administered at the Site of Tissue Injury in the Oral Surgery Model
|
Dionne, Raymond A.
|
|
2004
|
|
12 |
p. 1418-1424
|
artikel
|
| 12 |
Analysis of Drug Interactions Involving Fruit Beverages and Organic Anion-Transporting Polypeptides
|
Greenblatt, David J.
|
|
2009
|
|
12 |
p. 1403-1407
|
artikel
|
| 13 |
A New Cyclooxygenase-2 Inhibitor, Rofecoxib (VIOXX®), Did Not Alter the Antiplatelet Effects of Low-Dose Aspirin in Healthy Volunteers
|
Greenberg, Howard E.
|
|
2000
|
|
12 |
p. 1509-1515
|
artikel
|
| 14 |
Antimalarial Drug Therapy: The Role of Parasite Biology and Drug Resistance
|
Daily, Johanna P.
|
|
2006
|
|
12 |
p. 1487-1497
|
artikel
|
| 15 |
A Pharmacokinetic Evaluation of Concomitant Administration of Linezolid and Aztreonam
|
Sisson, Theresa Lasher
|
|
1999
|
|
12 |
p. 1277-1282
|
artikel
|
| 16 |
A Randomized Crossover Study Investigating the Influence of Ranitidine or Omeprazole on the Pharmacokinetics of Cephalexin Monohydrate
|
Madaras-Kelly, Karl
|
|
2004
|
|
12 |
p. 1391-1397
|
artikel
|
| 17 |
A Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial
|
Preston, Richard A.
|
|
2007
|
|
12 |
p. 1555-1569
|
artikel
|
| 18 |
A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone)
|
Constantinescu, Radu
|
|
2007
|
|
12 |
p. 1580-1586
|
artikel
|
| 19 |
A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation
|
Musuamba, Flora Tshinanu
|
|
2012
|
|
12 |
p. 1833-1843
|
artikel
|
| 20 |
Assessment of In Vivo CYP2D6 Activity: Differential Sensitivity of Commonly Used Probes to Urine pH
|
Özdemir, Mahmut
|
|
2004
|
|
12 |
p. 1398-1404
|
artikel
|
| 21 |
Assessment of Nevirapine Bioavailability From Targeted Sites in the Human Gastrointestinal Tract
|
Macha, Sreeraj
|
|
2009
|
|
12 |
p. 1417-1425
|
artikel
|
| 22 |
Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic-Controlled Extended-Release Methylphenidate Formulation in Humans
|
Parasrampuria, Dolly A.
|
|
2007
|
|
12 |
p. 1476-1488
|
artikel
|
| 23 |
A Study in Normal Human Volunteers to Compare the Rate and Extent of Levothyroxine Absorption from Synthroid® and Levoxine®
|
Berg, Jeffrey A.
|
|
1992
|
|
12 |
p. 1135-1140
|
artikel
|
| 24 |
A Study of the Pharmacokinetics of Azithromycin and Nelfinavir When Coadministered in Healthy Volunteers
|
Amsden, Guy W.
|
|
2000
|
|
12 |
p. 1522-1527
|
artikel
|
| 25 |
Author Index, Volume 44 (2004)
|
|
|
2004
|
|
12 |
p. 1428-1431
|
artikel
|
| 26 |
Author Index, Volume 45 (2005)
|
|
|
2005
|
|
12 |
p. 1442-1445
|
artikel
|
| 27 |
Author Index, Volume 46 (2006)
|
|
|
2006
|
|
12 |
p. 1501-1503
|
artikel
|
| 28 |
Author Index, Volume 39 (1999)
|
|
|
1999
|
|
12 |
p. 1294-1296
|
artikel
|
| 29 |
Author Index, Volume 40 (2000)
|
|
|
2000
|
|
12 |
p. 1528-1531
|
artikel
|
| 30 |
Azimilide Pharmacokinetics following Intravenous and Oral Administration of a Solution and Capsule Formulation
|
Corey, Alfred E.
|
|
1999
|
|
12 |
p. 1272-1276
|
artikel
|
| 31 |
Bioavailability and Metabolism of Prochlorperazine Administered via the Buccal and Oral Delivery Route
|
Finn, Andrew
|
|
2005
|
|
12 |
p. 1383-1390
|
artikel
|
| 32 |
Bioavailability Studies of Drugs with Nonlinear Pharmacokinetics: I. Tracer Dose AUC Varies Directly with Serum Concentration
|
Browne, T. R.
|
|
1992
|
|
12 |
p. 1141-1145
|
artikel
|
| 33 |
Bleeding Associated with Eptifibatide Targeting Higher Risk Patients with Acute Coronary Syndromes: Incidence and Multivariate Risk Factors
|
Rasty, Saeed
|
|
2002
|
|
12 |
p. 1366-1373
|
artikel
|
| 34 |
BookReview: Abdel-Magid AF, Caron S. Fundamentals of Early Clinical Drug Development: From Synthesis Design to Formulation. New York: John Wiley; 2006; 323 pp
|
Bhattacharjee, K.R.
|
|
2007
|
|
12 |
p. 1594-1594
|
artikel
|
| 35 |
BookReview: Books Available for Review
|
|
|
2007
|
|
12 |
p. 1594-1594
|
artikel
|
| 36 |
BookReview: Dubovsky SL, Dubovsky AN. Psychotropic Drug Prescriber's Survival Guide: Ethical Mental Treatment in the Age of Big Pharma. New York: W. W. Norton; 2007; 187 pp., $27.50
|
|
|
2007
|
|
12 |
p. 1592-1593
|
artikel
|
| 37 |
BookReview: Letter From the Section Editor
|
|
|
2007
|
|
12 |
p. 1594-1594
|
artikel
|
| 38 |
BookReview: Moyé LA. Statistical Reasoning in Medicine: The Intuitive P-Value Primer. 2nd ed. New York: Springer; 2006; 301 pp., $54.95
|
Korth-Bradley, Joan
|
|
2007
|
|
12 |
p. 1593-1593
|
artikel
|
| 39 |
Brivaracetam Disposition in Renal Impairment
|
Sargentini-Maier, Maria Laura
|
|
2012
|
|
12 |
p. 1927-1933
|
artikel
|
| 40 |
Clinical Manifestation of Atherosclerotic Peripheral Arterial Disease and the Role of Cilostazol in Treatment of Intermittent Claudication
|
Crouse, John Robert
|
|
2002
|
|
12 |
p. 1291-1298
|
artikel
|
| 41 |
Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
|
Venitz, Jürgen
|
|
2012
|
|
12 |
p. 1784-1805
|
artikel
|
| 42 |
Clinical Pharmacokinetics and Exposure-Toxicity Relationship of a Folate-Vinca Alkaloid Conjugate EC145 in Cancer Patients
|
Li, Jing
|
|
2009
|
|
12 |
p. 1467-1476
|
artikel
|
| 43 |
Clinical Pharmacokinetics and Pharmacodynamics of a New Squalene Synthase Inhibitor, BMS-188494, in Healthy Volunteers
|
Sharma, Amarnath
|
|
1998
|
|
12 |
p. 1116-1121
|
artikel
|
| 44 |
Clinical Pharmacokinetics of the CD19 Receptor-Directed Tyrosine Kinase Inhibitor B43-Genistein in Patients with B-Lineage Lymphoid Malignancies
|
Chen, Chun-lin
|
|
1999
|
|
12 |
p. 1248-1255
|
artikel
|
| 45 |
Clinical Pharmacokinetics of Vinorelbine Alone and Combined with Cisplatin
|
Levêque, Dominique
|
|
1992
|
|
12 |
p. 1096-1098
|
artikel
|
| 46 |
Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO-B) Inhibitor Rasagiline
|
Goren, Tamar
|
|
2010
|
|
12 |
p. 1420-1428
|
artikel
|
| 47 |
Clinical Therapeutic Conference
|
Somberg, John C.
|
|
1992
|
|
12 |
p. 1083-1088
|
artikel
|
| 48 |
Clinical Trials in Amyotrophic Lateral Sclerosis: The Tenuous Past and the Promising Future
|
Choudry, Rabia B.
|
|
2005
|
|
12 |
p. 1334-1344
|
artikel
|
| 49 |
Commentary on ACCP Position Statement on the Use of Microdosing in the Drug Development Process
|
Rowland, Malcolm
|
|
2007
|
|
12 |
p. 1595-1596
|
artikel
|
| 50 |
Comparative Effects of Verapamil and Volume Overload on Atrial Natriuretic Factors and the Renin-Angiotensin Aldosterone-Vasopressin System
|
Buckley, Jill Wikman
|
|
1992
|
|
12 |
p. 1120-1127
|
artikel
|
| 51 |
Comparison of Changes in the Lipid Profile of Postmenopausal Women With Early Stage Breast Cancer Treated With Exemestane or Letrozole
|
Bell, Lauren Nicole
|
|
2012
|
|
12 |
p. 1852-1860
|
artikel
|
| 52 |
Computerized Extraction of Electrocardiograms From Continuous 12-Lead Holter Recordings Reduces Measurement Variability in a Thorough QT Study
|
George, Samuel
|
|
2012
|
|
12 |
p. 1891-1900
|
artikel
|
| 53 |
Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity
|
McCrea, Jacqueline
|
|
1999
|
|
12 |
p. 1212-1220
|
artikel
|
| 54 |
Considerations in Analyzing Single-Trough Concentrations Using Mixed-Effects Modeling
|
Booth, Brian P.
|
|
2003
|
|
12 |
p. 1307-1315
|
artikel
|
| 55 |
Correlation Between Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid in Liver Transplant Patients
|
Shi Minmin,
|
|
2010
|
|
12 |
p. 1388-1396
|
artikel
|
| 56 |
Crossover Trials Should Not Be Used to Test One Treatment against Another Treatment with a Totally Different Chemical Class/Mode of Action
|
Cleophas, Ton J.
|
|
2000
|
|
12 |
p. 1503-1508
|
artikel
|
| 57 |
CYP2C9, CYP2C19, and ABCB1 Genotype and Hospitalization for Phenytoin Toxicity
|
Hennessy, Sean
|
|
2009
|
|
12 |
p. 1483-1487
|
artikel
|
| 58 |
Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use
|
Zhou, Limin
|
|
2005
|
|
12 |
p. 1345-1359
|
artikel
|
| 59 |
Demonstration of the Analgesic Efficacy and Dose-Response of Acetylsalicylic Acid With Pseudoephedrine
|
Schachtel, Bernard P.
|
|
2010
|
|
12 |
p. 1429-1437
|
artikel
|
| 60 |
Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children
|
Tremoulet, Adriana H.
|
|
2012
|
|
12 |
p. 1824-1832
|
artikel
|
| 61 |
Don’t Get Boxed In: Commentary on the Visual Inspection Practices to Assess Exposure-Response Relationships From Binary Clinical Variables
|
Mehrotra, Shailly
|
|
2012
|
|
12 |
p. 1912-1917
|
artikel
|
| 62 |
Dopamine-1 Receptor Agonist: Renal Effects and Its Potential Role in the Management of Radiocontrast-Induced Nephropathy
|
Asif, Arif
|
|
2004
|
|
12 |
p. 1342-1351
|
artikel
|
| 63 |
Dose-Dependent Alternations in the Pharmacokinetics of Olanzapine During Coadministration of Fluvoxamine in Patients With Schizophrenia
|
Chiu, Chih-Chiang
|
|
2004
|
|
12 |
p. 1385-1390
|
artikel
|
| 64 |
Dose Proportionality of Once-Daily Trazodone Extended-Release Caplets Under Fasting Conditions
|
Karhu, David
|
|
2010
|
|
12 |
p. 1438-1449
|
artikel
|
| 65 |
Dose Response and Safety of Telmisartan in Patients with Mild to Moderate Hypertension
|
Smith, David H. G.
|
|
2000
|
|
12 |
p. 1380-1390
|
artikel
|
| 66 |
Dosing Rationale for Liraglutide in Type 2 Diabetes Mellitus: A Pharmacometric Assessment
|
Ingwersen, Steen H.
|
|
2012
|
|
12 |
p. 1815-1823
|
artikel
|
| 67 |
DOV 216,303, a “Triple” Reuptake Inhibitor: Safety, Tolerability, and Pharmacokinetic Profile
|
Beer, Bernard
|
|
2004
|
|
12 |
p. 1360-1367
|
artikel
|
| 68 |
Drug-Drug and Drug-Food Interactions Between Tenofovir Disoproxil Fumarate and Didanosine
|
Kearney, Brian P.
|
|
2005
|
|
12 |
p. 1360-1367
|
artikel
|
| 69 |
Drug Interaction Studies of Therapeutic Proteins or Monoclonal Antibodies
|
Mahmood, Iftekhar
|
|
2007
|
|
12 |
p. 1540-1554
|
artikel
|
| 70 |
Dynamics and Kinetics of a Modified-Release Formulation of Zolpidem: Comparison With Immediate-Release Standard Zolpidem and Placebo
|
Greenblatt, David J.
|
|
2006
|
|
12 |
p. 1469-1480
|
artikel
|
| 71 |
Effect of Application Sites and Multiple Doses on Nicotine Pharmacokinetics in Healthy Male Japanese Smokers Following Application of the Transdermal Nicotine Patch
|
Sobue, Satoshi
|
|
2005
|
|
12 |
p. 1391-1399
|
artikel
|
| 72 |
Effect of a Triphasic Oral Contraceptive on Drug-Metabolizing Enzyme Activity as Measured by the Validated Cooperstown 5+1 Cocktail
|
Shelepova, Tatiana
|
|
2005
|
|
12 |
p. 1413-1421
|
artikel
|
| 73 |
Effect of Dietary Fat Content in Meals on Pharmacokinetics of Quazepam
|
Yasui-Furukori, Norio
|
|
2002
|
|
12 |
p. 1335-1340
|
artikel
|
| 74 |
Effect of Food and Food Composition on Alcohol Elimination Rates in Healthy Men and Women
|
Ramchandani, Vijay A.
|
|
2001
|
|
12 |
p. 1345-1350
|
artikel
|
| 75 |
Effect of Food on Pharmacokinetics of an Inhaled Drug: A Case Study with A VLA-4Antagonist, HMR1031
|
Shah, Bharti
|
|
2003
|
|
12 |
p. 1341-1349
|
artikel
|
| 76 |
Effect of High-Dose Metronidazole on Pharmacokinetics of Oral Budesonide and Vice Versa: A Double Drug Interaction Study
|
Dilger, Karin
|
|
2007
|
|
12 |
p. 1532-1539
|
artikel
|
| 77 |
Effect of Influenza Immunization on CYP3A4 Activity in Vivo
|
Hayney, Mary S.
|
|
2003
|
|
12 |
p. 1377-1381
|
artikel
|
| 78 |
Effect of Lasofoxifene on the Pharmacokinetics of Digoxin in Healthy Postmenopausal Women
|
Roman, Doina
|
|
2005
|
|
12 |
p. 1407-1412
|
artikel
|
| 79 |
Effect of Modafinil on Acute Pain: A Randomized Double-Blind Crossover Study
|
Taneja, Indu
|
|
2004
|
|
12 |
p. 1425-1427
|
artikel
|
| 80 |
Effect of Raltegravir on the Pharmacokinetics of Methadone
|
Anderson, Matt S.
|
|
2010
|
|
12 |
p. 1461-1466
|
artikel
|
| 81 |
Effect of Renal Function on the Pharmacokinetics of Palifermin
|
Gillespie, B.
|
|
2006
|
|
12 |
p. 1460-1468
|
artikel
|
| 82 |
Effects of Cholestyramine on Vitamin E Levels in Patients Treated with Statins
|
Kersting, Friedrich
|
|
2000
|
|
12 |
p. 1476-1479
|
artikel
|
| 83 |
Effects of COER-Verapamil on Circadian Pattern of Forearm Vascular Resistance and Blood Pressure
|
Nguyen, B. Nhi T.
|
|
2000
|
|
12 |
p. 1480-1487
|
artikel
|
| 84 |
Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of Warfarin at Steady State in Healthy Subjects
|
Chappell, Jill
|
|
2009
|
|
12 |
p. 1456-1466
|
artikel
|
| 85 |
Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet
|
Schwartz, Jules I.
|
|
2007
|
|
12 |
p. 1521-1531
|
artikel
|
| 86 |
Effects of Meals and Meal Composition on the Bioavailability of Fenretinide
|
Doose, Dennis R.
|
|
1992
|
|
12 |
p. 1089-1095
|
artikel
|
| 87 |
Efficacy and Safety of Vernakalant in Recent-Onset Atrial Fibrillation After the European Medicines Agency Approval: Systematic Review and Meta-Analysis
|
Buccelletti, Francesco
|
|
2012
|
|
12 |
p. 1872-1878
|
artikel
|
| 88 |
Efficacy, Safety, and Tolerability of Aliskiren Monotherapy Administered With a Light Meal in Elderly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Evaluation Study
|
Villa, Giuseppe
|
|
2012
|
|
12 |
p. 1901-1911
|
artikel
|
| 89 |
Efflux Transporter-Mediated Interactions With Atorvastatin—Interesting Findings With Multiple Substrates: Istradefylline, Verapamil, and Rifampicin
|
Srinivas, Nuggehally R.
|
|
2009
|
|
12 |
p. 1492-1493
|
artikel
|
| 90 |
Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6
|
Walsky, Robert L.
|
|
2006
|
|
12 |
p. 1426-1438
|
artikel
|
| 91 |
Evaluation of Student Achievement and Educational Outcomes
|
Williams, Patricia B.
|
|
2001
|
|
12 |
p. 1259-1270
|
artikel
|
| 92 |
Grapefruit-Drug Interactions: Can Interactions With Drugs Be Avoided?
|
Mertens-Talcott, S. U.
|
|
2006
|
|
12 |
p. 1390-1416
|
artikel
|
| 93 |
Highlightsand Book Review: Bansal S, DeStefano A. Key elements of bioanalytical method validation for small molecules. AAPS J. 2007;9:Article 11
|
|
|
2007
|
|
12 |
p. 1590-1590
|
artikel
|
| 94 |
Highlightsand Book Review: Barrett JS, Gupta M, Mondick JT. Model-based drug development applied to oncology. Expert Opin Drug Discov. 2007;2:185-209. Kummar S, Gutierrez M, Doroshow JH, Murgo A. Drug development in oncology: classic cytotoxics and molecularly targeted agents. Br J Clin Pharmacol. 2006;62:15-26
|
|
|
2007
|
|
12 |
p. 1588-1588
|
artikel
|
| 95 |
Highlightsand Book Review: Bauer RJ, Guzy S, Ng C. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. AAPS J. 2007; 9:Article 7
|
|
|
2007
|
|
12 |
p. 1588-1589
|
artikel
|
| 96 |
Highlightsand Book Review: Ellenbogen JM, Hu PT, Payne JD, Titone D, Walker M. Human relational memory requires time and sleep. Proc Natl Acad Sci USA. 2007;104:7723-7728
|
|
|
2007
|
|
12 |
p. 1589-1590
|
artikel
|
| 97 |
Highlightsand Book Review: Kallen A. A simple absorption model for dose-escalating studies. J Pharmacokinet Pharmacodyn. 2007;34:251-261
|
|
|
2007
|
|
12 |
p. 1591-1591
|
artikel
|
| 98 |
Highlightsand Book Review: Liu M, Wei L, Zhang J. Review of guidelines and literature for handling missing data in longitudinal clinical trials with a case study. Pharm Stat. 2006;5:7-18
|
|
|
2007
|
|
12 |
p. 1591-1591
|
artikel
|
| 99 |
Highlightsand Book Review: Ludbrook J. Writing intelligible prose for biomedical journals. Clin Exp Pharmacol Physiol. 2007;34:508-514
|
|
|
2007
|
|
12 |
p. 1591-1591
|
artikel
|
| 100 |
Highlightsand Book Review: Research Highlights
|
Bonate, Peter L.
|
|
2007
|
|
12 |
p. 1587-1587
|
artikel
|
| 101 |
Highlightsand Book Review: Reynolds KK, Valdes R Jr, Hartung BR, Linder MW. Individualizing warfarin therapy. Future Med. 2007;4:11-31
|
|
|
2007
|
|
12 |
p. 1590-1590
|
artikel
|
| 102 |
Highlights and Book Reviews
|
|
|
2006
|
|
12 |
p. 1498-1500
|
artikel
|
| 103 |
Highlightsand Book Review: Yengi LG, Leung L, Kao J. The evolving role of drug metabolism in drug discovery and development. Pharm Res. 2007;24:842-858. Testa B, Kramer S. The biochemistry of drug metabolism—an introduction: Part 1. Principles and overview. Chem Biodiversity. 2006;3:1053-1101. Testa B, Kramer S. The biochemistry of drug metabolism—an introduction: Part 2. Redox reactions and their enzymes. Chem Biodiversity. 2007;4:257-405
|
|
|
2007
|
|
12 |
p. 1591-1592
|
artikel
|
| 104 |
Highlightsand Book Review: Zandvliet AS, Huitema ADR, Copalu W, et al. CYP2C9 and CYP2C19 polymorphic forms are related to increased indisulam exposure of higher risk of severe hematologic malignancy. Clin Cancer Res. 2007;13:2970-2976
|
|
|
2007
|
|
12 |
p. 1592-1592
|
artikel
|
| 105 |
Homocysteine and Essential Hypertension
|
Rodrigo, Ramón
|
|
2003
|
|
12 |
p. 1299-1306
|
artikel
|
| 106 |
Human Kinetics of Orally and Intravenously Administered Low-Dose 1,2-13C-Dichloroacetate
|
Jia, Minghong
|
|
2006
|
|
12 |
p. 1449-1459
|
artikel
|
| 107 |
Hypersensitivity Syndrome Induced by Anticonvulsants: Possible Cross-Reactivity Between Carbamazepine and Lamotrigine
|
Aouam, Karim
|
|
2009
|
|
12 |
p. 1488-1491
|
artikel
|
| 108 |
Identification of the Mechanism of Action of a Glucokinase Activator From Oral Glucose Tolerance Test Data in Type 2 Diabetic Patients Based on an Integrated Glucose-Insulin Model
|
Jauslin, Petra M.
|
|
2012
|
|
12 |
p. 1861-1871
|
artikel
|
| 109 |
Influence of Body Weight and Gender on the Pharmacokinetics, Pharmacodynamics, and Antihypertensive Efficacy of Aliskiren
|
Jarugula, Venkateswar
|
|
2010
|
|
12 |
p. 1358-1366
|
artikel
|
| 110 |
Influence of Chronic Renal Failure on Stereoselective Metoprolol Metabolism in Hypertensive Patients
|
Cerqueira, Paula Macedo
|
|
2005
|
|
12 |
p. 1422-1433
|
artikel
|
| 111 |
Integrated Pharmacokinetic/Pharmacodynamic Model of XV459, a Potent and Specific GpIIb/IIIa Inhibitor, in Healthy Male Volunteers
|
Fossler, Michael J.
|
|
2002
|
|
12 |
p. 1326-1334
|
artikel
|
| 112 |
Interaction Study between Fluvoxamine and Quazepam
|
Kanda, Hideto
|
|
2003
|
|
12 |
p. 1392-1397
|
artikel
|
| 113 |
Interindividual and Intraindividual Variability of the Urinary 6β-Hydroxycortisol/Cortisol Ratio in Chinese Subjects: Implications of Its Use for Evaluating CYP3A Activity
|
Yin, Ophelia Q.P.
|
|
2004
|
|
12 |
p. 1412-1417
|
artikel
|
| 114 |
Interspecies Scaling: Role of Protein Binding in the Prediction of Clearance from Animals to Humans
|
Mahmood, Iftekhar
|
|
2000
|
|
12 |
p. 1439-1446
|
artikel
|
| 115 |
Introduction
|
Keefe, Deborah L.
|
|
2000
|
|
12 |
p. 1311-1311
|
artikel
|
| 116 |
Iron Supplementation in Preterm Infants: A Study Comparing the Effect and Tolerance of a Fe2+ and a Nonionic FeIII Compound
|
Naude, S.
|
|
2000
|
|
12 |
p. 1447-1451
|
artikel
|
| 117 |
Laboratory Values and Vital Signs in Male Smokers and Nonsmokers in Phase I Trials: A Retrospective Comparison
|
Merz, M.
|
|
1998
|
|
12 |
p. 1144-1150
|
artikel
|
| 118 |
Lack of Electrocardiographic Effect of Dexlansoprazole MR, a Novel Modified-Release Formulation of the Proton Pump Inhibitor Dexlansoprazole, in Healthy Participants
|
Vakily, Majid
|
|
2009
|
|
12 |
p. 1447-1455
|
artikel
|
| 119 |
Lack of Enzyme-Inducing Effect of Rifampicin on the Pharmacokinetics of Enfuvirtide
|
Boyd, Mark Alastair
|
|
2003
|
|
12 |
p. 1382-1391
|
artikel
|
| 120 |
Lack of Pharmacokinetic Interaction between Lansoprazole and Intravenously Administered Phenytoin
|
Karol, Michael D.
|
|
1999
|
|
12 |
p. 1283-1289
|
artikel
|
| 121 |
Laropiprant in Combination With Extended-Release Niacin Does Not Alter Urine 11-Dehydrothromboxane B2, a Marker of In Vivo Platelet Function, in Healthy, Hypercholesterolemic, and Diabetic Subjects
|
Lauring, Brett
|
|
2009
|
|
12 |
p. 1426-1435
|
artikel
|
| 122 |
Levetiracetam: Relative Bioavailability and Bioequivalence of a 10% Oral Solution (750 mg) and 750-mg Tablets
|
Coupez, René
|
|
2003
|
|
12 |
p. 1370-1376
|
artikel
|
| 123 |
Limits of Confidence in Tracer Compounds as a Means of Measuring Patient Compliance with Medication
|
Shine, Daniel
|
|
1999
|
|
12 |
p. 1233-1241
|
artikel
|
| 124 |
Lipid and Lipoprotein Responses to Oral Combined Hormone Replacement Therapy in Normolipemic Obese Women with Controlled Type 2 Diabetes Mellitus
|
Lilley, Sandra H.
|
|
1998
|
|
12 |
p. 1107-1115
|
artikel
|
| 125 |
Matrix Metalloproteinases and Abdominal Aortic Aneurysms: A Potential Therapeutic Target
|
Sinha, Sanjai
|
|
1998
|
|
12 |
p. 1077-1088
|
artikel
|
| 126 |
Metabolism by N-Acetyltransferase 1 In Vitro and in Healthy Volunteers: A Prototype for Targeted Inhibition
|
Cantilena, Louis R.
|
|
2004
|
|
12 |
p. 1405-1411
|
artikel
|
| 127 |
Microdose Pharmacokinetics of IDX899 and IDX989, Candidate HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors, Following Oral and Intravenous Administration in Healthy Male Subjects
|
Zhou, Xiao-Jian
|
|
2009
|
|
12 |
p. 1408-1416
|
artikel
|
| 128 |
Microsomal Enzyme Induction and Clinical Aggravation of Porphyria: The Evaluation of Human Urinary 6β-Hydroxycortisol/Cortisol Ratio as the Index of Hepatic CYP3A4 Activity
|
Uejima, Etsuko
|
|
2002
|
|
12 |
p. 1374-1379
|
artikel
|
| 129 |
Multiple-Dose Pharmacokinetics of Telmisartan and of Hydrochlorothiazide following Concurrent Administration in Healthy Subjects
|
Yong, Chan-Loi
|
|
2000
|
|
12 |
p. 1323-1330
|
artikel
|
| 130 |
Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers
|
Faessel, Hélène M.
|
|
2006
|
|
12 |
p. 1439-1448
|
artikel
|
| 131 |
No Effect of Rosuvastatin on the Pharmacokinetics of Digoxin in Healthy Volunteers
|
Martin, Paul D.
|
|
2002
|
|
12 |
p. 1352-1357
|
artikel
|
| 132 |
No Effect of the Novel Antidiabetic Agent Nateglinide on the Pharmacokinetics and Anticoagulant Properties of Warfarin in Healthy Volunteers
|
Anderson, Denise M.
|
|
2002
|
|
12 |
p. 1358-1365
|
artikel
|
| 133 |
NXY-059 Does Not Significantly Interact With Furosemide in Healthy Volunteers
|
Strid, Stig
|
|
2006
|
|
12 |
p. 1417-1425
|
artikel
|
| 134 |
Omapatrilat: Neurohormonal and Pharmacodynamic Profile When Administered with Furosemide
|
Uderman, Howard
|
|
2001
|
|
12 |
p. 1291-1300
|
artikel
|
| 135 |
Onset and Duration of Analgesia for Low-Dose Ketoprofen in the Treatment of Postoperative Dental Pain
|
Sunshine, Abraham
|
|
1998
|
|
12 |
p. 1155-1164
|
artikel
|
| 136 |
Opiate Antagonists and Eating Behavior in Humans: A Review
|
de Zwaan, Martina
|
|
1992
|
|
12 |
p. 1060-1072
|
artikel
|
| 137 |
Optimizing the Use of Biomarkers, Surrogate Endpoints, and Clinical Endpoints for More Efficient Drug Development
|
Colburn, Wayne A.
|
|
2000
|
|
12 |
p. 1419-1427
|
artikel
|
| 138 |
P-glycoprotein (P-gp) Is Upregulated in Peripheral T-Cell Subsets from Solid Organ Transplant Recipients
|
Donnenberg, Vera S.
|
|
2001
|
|
12 |
p. 1271-1279
|
artikel
|
| 139 |
Pharmaceutical Costs
|
Somberg, John C.
|
|
1992
|
|
12 |
p. 1059-1059
|
artikel
|
| 140 |
Pharmacodynamic Effects of Steady-State Fingolimod on Antibody Response in Healthy Volunteers: A 4-Week, Randomized, Placebo-Controlled, Parallel-Group, Multiple-Dose Study
|
Boulton, Craig
|
|
2012
|
|
12 |
p. 1879-1890
|
artikel
|
| 141 |
Pharmacodynamics and Pharmacokinetics of AMG 531, a Thrombopoiesis-Stimulating Peptibody, in Healthy Japanese Subjects: A Randomized, Placebo-Controlled Study
|
Kumagai, Yuji
|
|
2007
|
|
12 |
p. 1489-1497
|
artikel
|
| 142 |
Pharmacodynamics and Pharmacokinetics of a Single Oral Dose of Nitrazepam in Healthy Volunteers: An Interethnic Comparative Study between Japanese and European Volunteers
|
van Gerven, J. M. A.
|
|
1998
|
|
12 |
p. 1129-1136
|
artikel
|
| 143 |
Pharmacodynamics and Pharmacokinetics of Omapatrilat in Heart Failure
|
Kostis, John B.
|
|
2001
|
|
12 |
p. 1280-1290
|
artikel
|
| 144 |
Pharmacokinetic and Pharmacodynamic Characteristics and Safety of Inhaled Albuterol Enantiomers in Healthy Volunteers
|
Gumbhir-Shah, Kavita
|
|
1998
|
|
12 |
p. 1096-1106
|
artikel
|
| 145 |
Pharmacokinetic and Pharmacodynamic Profiles of BIA 3-202, a Novel Catechol- O -Methyltransferase (COMT) Inhibitor, during Multiple-Dose Administration to Healthy Subjects
|
Almeida, Luis
|
|
2003
|
|
12 |
p. 1350-1360
|
artikel
|
| 146 |
Pharmacokinetic and Safety Assessments of Galantamine and Risperidone after the Two Drugs Are Administered Alone and Together
|
Huang, Fenglei
|
|
2002
|
|
12 |
p. 1341-1351
|
artikel
|
| 147 |
Pharmacokinetic Changes of Theophylline and Amikacin through the Menstrual Cycle in Healthy Women
|
Matsuki, Shunji
|
|
1999
|
|
12 |
p. 1256-1262
|
artikel
|
| 148 |
Pharmacokinetic/Pharmacodynamic Modeling in Drug Research and Development
|
Derendorf, Hartmut
|
|
2000
|
|
12 |
p. 1399-1418
|
artikel
|
| 149 |
Pharmacokinetics and Bioavailability of a Metformin/Glyburide Tablet Administered Alone and with Food
|
Marathe, P. H.
|
|
2000
|
|
12 |
p. 1494-1502
|
artikel
|
| 150 |
Pharmacokinetics and Dosage Adaptation of Meropenem during Continuous Venovenous Hemodiafiltration in Critically Ill Patients
|
Robatel, C.
|
|
2003
|
|
12 |
p. 1329-1340
|
artikel
|
| 151 |
Pharmacokinetics and Pharmacodynamics following Intravenous Doses of Azimilide Dihydrochioride
|
Corey, Alfred
|
|
1999
|
|
12 |
p. 1263-1271
|
artikel
|
| 152 |
Pharmacokinetics and Pharmacodynamics of Famotidine in Infants
|
James, Laura P.
|
|
1998
|
|
12 |
p. 1089-1095
|
artikel
|
| 153 |
Pharmacokinetics and Pharmacodynamics of Mesna-Mediated Plasma Cysteine Depletion
|
Smith, Patrick F.
|
|
2003
|
|
12 |
p. 1324-1328
|
artikel
|
| 154 |
Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects
|
Mousa, Shaker A.
|
|
2007
|
|
12 |
p. 1508-1520
|
artikel
|
| 155 |
Pharmacokinetics and Safety of a Single Oral Dose of Once-Daily Alfuzosin, 10 mg, in Male Subjects with Mild to Severe Renal Impairment
|
Marbury, Thomas C.
|
|
2002
|
|
12 |
p. 1311-1317
|
artikel
|
| 156 |
Pharmacokinetics and Safety of Intravenous and Oral Telmisartan 20 mg and 120 mg in Subjects with Hepatic Impairment Compared with Healthy Volunteers
|
Stangier, Joachim
|
|
2000
|
|
12 |
p. 1355-1364
|
artikel
|
| 157 |
Pharmacokinetics and Safety of Oral Eletriptan during Different Phases of the Menstrual Cycle in Healthy Volunteers
|
Shah, Ajit K.
|
|
2001
|
|
12 |
p. 1339-1344
|
artikel
|
| 158 |
Pharmacokinetics and Tolerability of an Antiangiogenic Ribozyme (ANGIOZYME™) in Healthy Volunteers
|
Sandberg, Jennifer A.
|
|
2000
|
|
12 |
p. 1462-1469
|
artikel
|
| 159 |
Pharmacokinetics and Tolerability of Buspirone during Oral Administration to Children and Adolescents with Anxiety Disorder and Normal Healthy Adults
|
Salazar, Daniel E.
|
|
2001
|
|
12 |
p. 1351-1358
|
artikel
|
| 160 |
Pharmacokinetics of Acetaminophen and Ibuprofen When Coadministered with Telmisartan in Healthy Volunteers
|
Stangier, Joachim
|
|
2000
|
|
12 |
p. 1338-1346
|
artikel
|
| 161 |
Pharmacokinetics of a Sustained-Release Dosage Form of Clomipramine
|
Herrera, Dea
|
|
2000
|
|
12 |
p. 1488-1493
|
artikel
|
| 162 |
Pharmacokinetics of Dapoxetine Hydrochloride in Healthy Chinese, Japanese, and Caucasian Men
|
Thyssen, An
|
|
2010
|
|
12 |
p. 1450-1460
|
artikel
|
| 163 |
Pharmacokinetics of E5564, a Lipopolysaccharide Antagonist, in Patients with Impaired Hepatic Function
|
Liang, Earvin
|
|
2003
|
|
12 |
p. 1361-1369
|
artikel
|
| 164 |
Pharmacokinetics of Intravenous Itraconazole followed by Itraconazole Oral Solution in Patients with Human Immunodeficiency Virus Infection
|
Zhao, Qinying
|
|
2001
|
|
12 |
p. 1319-1328
|
artikel
|
| 165 |
Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis
|
Nianhang Chen,
|
|
2007
|
|
12 |
p. 1466-1475
|
artikel
|
| 166 |
Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise
|
Abrams, Larry S.
|
|
2001
|
|
12 |
p. 1301-1309
|
artikel
|
| 167 |
Pharmacokinetics of Pilocarpine in Subjects with Varying Degrees of Renal Function
|
St.Peter, John V.
|
|
2000
|
|
12 |
p. 1470-1475
|
artikel
|
| 168 |
Pharmacokinetics of Repeated Oral Doses of Amlodipine and Amlodipine plus Telmisartan in Healthy Volunteers
|
Stangier, Joachim
|
|
2000
|
|
12 |
p. 1347-1354
|
artikel
|
| 169 |
Pharmacokinetics of Single-Dose Telmisartan 120 mg Given during and between Hemodialysis in Subjects with Severe Renal Insufficiency: Comparison with Healthy Volunteers
|
Stangier, Joachim
|
|
2000
|
|
12 |
p. 1365-1372
|
artikel
|
| 170 |
Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Mild to Moderate Hepatic Impairment
|
Zimmerman, James J.
|
|
2005
|
|
12 |
p. 1368-1372
|
artikel
|
| 171 |
Pharmacokinetics of Sotalol Enantiomers in Humans
|
Carr, Robert A.
|
|
1992
|
|
12 |
p. 1105-1109
|
artikel
|
| 172 |
Pharmacokinetics of Trans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
|
Nunes, Teresa
|
|
2009
|
|
12 |
p. 1477-1482
|
artikel
|
| 173 |
Pharmacokinetics, Pharmacodynamics, and Safety of Tolvaptan, a Nonpeptide AVP Antagonist, During Ascending Single-Dose Studies in Healthy Subjects
|
Shoaf, Susan E.
|
|
2007
|
|
12 |
p. 1498-1507
|
artikel
|
| 174 |
Pharmacokinetics/Pharmacodynamics in Drug Development: An Industrial Perspective
|
Chaikin, Philip
|
|
2000
|
|
12 |
p. 1428-1438
|
artikel
|
| 175 |
Pharmacokinetics, Safety, and Tolerability of R411, a Dual α4β1-α4β7 Integrin Antagonist After Oral Administration at Single and Multiple Once-Daily Ascending Doses in Healthy Volunteers
|
Hijazi, Youssef
|
|
2004
|
|
12 |
p. 1368-1378
|
artikel
|
| 176 |
Pioglitazone: Effect on CYP3A4 Activity
|
Nowak, Sandra N.
|
|
2002
|
|
12 |
p. 1299-1302
|
artikel
|
| 177 |
Polymorphisms and the Pocketbook: The Cost-Effectiveness of Cytochrome P450 2C19 Genotyping in the Eradication of Helicobacter Pylori Infection Associated with Duodenal Ulcer
|
Lehmann, David F.
|
|
2003
|
|
12 |
p. 1316-1323
|
artikel
|
| 178 |
Population Pharmacokinetics of Rituximab in Patients With Chronic Lymphocytic Leukemia
|
Li, Jing
|
|
2012
|
|
12 |
p. 1918-1926
|
artikel
|
| 179 |
Potential Benefits of Combined N-Acetylcysteine and Ciprofloxacin Therapy in Partial Biliary Obstruction
|
Ozdil, Burhan
|
|
2010
|
|
12 |
p. 1414-1419
|
artikel
|
| 180 |
Pregnancy Outcome Following Exposure to Topical Retinoids: A Multicenter Prospective Study
|
Panchaud, Alice
|
|
2012
|
|
12 |
p. 1844-1851
|
artikel
|
| 181 |
Preliminary Evaluation of Progestins as Inducers of Cytochrome P450 3A4 Activity in Postmenopausal Women
|
Tsunoda, Shirley M.
|
|
1998
|
|
12 |
p. 1137-1143
|
artikel
|
| 182 |
Pyrazinoylguanidine: Antihypertensive, Hypocholesterolemic, and Renin Efects
|
Chambers, Charles E.
|
|
1992
|
|
12 |
p. 1128-1134
|
artikel
|
| 183 |
Quantifying Pain Relief Following Administration of a Novel Formulation of Paracetamol (Acetaminophen)
|
Green, Bruce
|
|
2010
|
|
12 |
p. 1406-1413
|
artikel
|
| 184 |
Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Vitamin B Complex in the Treatment of Nocturnal Leg Cramps in Elderly Patients with Hypertension
|
Chan, Paul
|
|
1998
|
|
12 |
p. 1151-1154
|
artikel
|
| 185 |
Response to Comments on ACCP Position Statement on Microdosing
|
Bertino, Joseph S.
|
|
2007
|
|
12 |
p. 1597-1598
|
artikel
|
| 186 |
Reviews: Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look
|
Ling, Jie
|
|
2009
|
|
12 |
p. 1382-1402
|
artikel
|
| 187 |
Rosiglitazone Does Not Affect the Steady-State Pharmacokinetics of Digoxin
|
Di Cicco, Robert A.
|
|
2000
|
|
12 |
p. 1516-1521
|
artikel
|
| 188 |
Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin
|
Dowell, James A.
|
|
2005
|
|
12 |
p. 1373-1382
|
artikel
|
| 189 |
Severe Life-Threatening Hyponatremia during Paroxetine Therapy
|
Odeh, Majed
|
|
1999
|
|
12 |
p. 1290-1291
|
artikel
|
| 190 |
Single- and Multiple-Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, in Adults
|
Han, Tae H.
|
|
2010
|
|
12 |
p. 1367-1376
|
artikel
|
| 191 |
Single-Dose and Steady-State Pharmacokinetic and Pharmacodynamic Evaluation of Therapeutically Clinically Equivalent Doses of Inhaled Fluticasone Propionate and Budesonide, Given as Diskus® or Turbohaler®Dry-Powder Inhalers to Healthy Subjects
|
Möllmann, Helmut
|
|
2001
|
|
12 |
p. 1329-1338
|
artikel
|
| 192 |
Steady-State Pharmacodynamics and Pharmacokinetics of Warfarin in the Presence and Absence of Telmisartan in Healthy Male Volunteers
|
Stangier, Joachim
|
|
2000
|
|
12 |
p. 1331-1337
|
artikel
|
| 193 |
Subject Index, Volume 45 (2005)
|
|
|
2005
|
|
12 |
p. 1446-1459
|
artikel
|
| 194 |
Subject Index, Volume 44 (2004)
|
|
|
2004
|
|
12 |
p. 1432-1442
|
artikel
|
| 195 |
Subject Index, Volume 39 (1999)
|
|
|
1999
|
|
12 |
p. 1297-1303
|
artikel
|
| 196 |
Subject Index, Volume 46 (2006)
|
|
|
2006
|
|
12 |
p. 1504-1515
|
artikel
|
| 197 |
Subject Index, Volume 40 (2000)
|
|
|
2000
|
|
12 |
p. 1532-1541
|
artikel
|
| 198 |
Tamsulosin Exposure Is Significantly Increased by the CYP2D6*10/*10 Genotype
|
Choi, Chang-Ik
|
|
2012
|
|
12 |
p. 1934-1938
|
artikel
|
| 199 |
Teaching Clinical Pharmacology Using Team-Based Learning: A Comparison Between Third- and Fourth-Year Medical Students
|
Bou Akl, Imad
|
|
2012
|
|
12 |
p. 1806-1814
|
artikel
|
| 200 |
The Anticholinergic Drug Scale as a Measure of Drug-Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity
|
Carnahan, Ryan M.
|
|
2006
|
|
12 |
p. 1481-1486
|
artikel
|
| 201 |
The Contribution of P-glycoprotein to Pharmacokinetic Drug-Drug Interactions
|
Yu, Dale K.
|
|
1999
|
|
12 |
p. 1203-1211
|
artikel
|
| 202 |
The Effect of Antacid and Ranitidine on Droxicam Pharmacokinetics
|
Bartlett, A.
|
|
1992
|
|
12 |
p. 1115-1119
|
artikel
|
| 203 |
The Effect of Food on the Pharmacokinetics of a Dual Angiotensin-Converting Enzyme/Neutral Endopeptidase Inhibitor, M100240
|
Cirillo, Iolanda
|
|
2004
|
|
12 |
p. 1379-1384
|
artikel
|
| 204 |
The Effect of Food or Sucralfate on the Bioavailability of S(+) and R(−) Enantiomers of Ibuprofen
|
Levine, M. A. H.
|
|
1992
|
|
12 |
p. 1110-1114
|
artikel
|
| 205 |
The Effect of Intravenous Haloperidol on QT Interval Dispersion in Critically Ill Patients: Comparison with QT Interval Prolongation for Assessment of Risk of Torsades de Pointes
|
Tisdale, James E.
|
|
2001
|
|
12 |
p. 1310-1318
|
artikel
|
| 206 |
The Effect of Telmisartan on the Steady-State Pharmacokinetics of Digoxin in Healthy Male Volunteers
|
Stangier, Joachim
|
|
2000
|
|
12 |
p. 1373-1379
|
artikel
|
| 207 |
The Frequency of Caffeine Withdrawal in a Population-Based Survey and in a Controlled, Blinded Pilot Experiment
|
Dews, Peter B.
|
|
1999
|
|
12 |
p. 1221-1232
|
artikel
|
| 208 |
The Influence of Diltiazem Versus Cimetidine on Propranolol Metabolism
|
Tateishi, Tomonori
|
|
1992
|
|
12 |
p. 1099-1104
|
artikel
|
| 209 |
The Pharmacokinetics of Escitalopram After Oral and Intravenous Administration of Single and Multiple Doses to Healthy Subjects
|
Søgaard, B.
|
|
2005
|
|
12 |
p. 1400-1406
|
artikel
|
| 210 |
The Pharmacokinetics of Oral Ranitidine in Children and Adolescents with Cystic Fibrosis
|
James, Laura P.
|
|
1999
|
|
12 |
p. 1242-1247
|
artikel
|
| 211 |
The Pharmacokinetics of Toborinone in Subjects with Congestive Heart Failure and Concomitant Renal Impairment and/or Concomitant Hepatic Impairment
|
Tammara, Brinda
|
|
2002
|
|
12 |
p. 1318-1325
|
artikel
|
| 212 |
TherapeuticReview: Antiretroviral Drugs
|
Warnke, David
|
|
2007
|
|
12 |
p. 1570-1579
|
artikel
|
| 213 |
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of RO5068760, an MEK Inhibitor, in Healthy Volunteers: Assessment of Target Suppression
|
Lee, Lucy
|
|
2010
|
|
12 |
p. 1397-1405
|
artikel
|
| 214 |
The Single-Dose Pharmacokinetics of Midazolam and Its Primary Metabolite in Pediatric Patients after Oral and Intravenous Administration
|
Reed, Michael D.
|
|
2001
|
|
12 |
p. 1359-1369
|
artikel
|
| 215 |
Understanding the Relative Roles of Pharmacogenetics and Ontogeny in Pediatric Drug Development and Regulatory Science
|
Leeder, J. Steven
|
|
2010
|
|
12 |
p. 1377-1387
|
artikel
|
| 216 |
Utility of Sparse Concentration Sampling for Citalopram in Elderly Clinical Trial Subjects
|
Bies, Robert R.
|
|
2004
|
|
12 |
p. 1352-1359
|
artikel
|
Tijdschrift beschrijving